-+ 0.00%
-+ 0.00%
-+ 0.00%

SCISPARC: NEUROTHERA LABS ANNOUNCES INITIATION OF PHASE IIB CLINICAL TRIAL AT HANNOVER MEDICAL SCHOOL IN GERMANY FOR INNOVATIVE TREATMENT OF TOURETTE SYNDROME

Reuters·07/15/2026 12:41:43

Please log in to view news